sb 203580 has been researched along with ginsenoside rb1 in 2 studies
| Studies (sb 203580) | Trials (sb 203580) | Recent Studies (post-2010) (sb 203580) | Studies (ginsenoside rb1) | Trials (ginsenoside rb1) | Recent Studies (post-2010) (ginsenoside rb1) |
|---|---|---|---|---|---|
| 3,489 | 4 | 1,137 | 568 | 3 | 382 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jung, SH; Manickam, M; Namasivayam, V; Pillaiyar, T | 1 |
| Li, G; Qian, W; Zhao, C | 1 |
1 review(s) available for sb 203580 and ginsenoside rb1
| Article | Year |
|---|---|
Inhibitors of Melanogenesis: An Updated Review.
Topics: alpha-MSH; Biphenyl Compounds; Crystallization; Enzyme Inhibitors; Humans; Melanins; Monophenol Monooxygenase; Peptidomimetics; Radiation, Ionizing; Resveratrol; Signal Transduction; Skin | 2018 |
1 other study(ies) available for sb 203580 and ginsenoside rb1
| Article | Year |
|---|---|
Analyzing the anti-ischemia-reperfusion injury effects of ginsenoside Rb1 mediated through the inhibition of p38α MAPK.
Topics: Animals; Cardiotonic Agents; Caspase 3; Ginsenosides; Imidazoles; Male; Mitogen-Activated Protein Kinase 14; Myocardial Infarction; Myocardial Reperfusion Injury; Phosphorylation; Protein Kinase Inhibitors; Pyridines; Rats; Rats, Sprague-Dawley; Tumor Necrosis Factor-alpha | 2016 |